Resolute Energy Corporation Announces Closing of Delaware Basin Bronco Acquisition
May 15, 2017 20:08 pm UTC| Business
DENVER, May 15, 2017 -- Resolute Energy Corporation (“Resolute” or the “Company”) (NYSE:REN) today announced the closing of its previously announced Bronco acquisition of certain oil and gas properties located in Reeves...
Resolute Energy Corporation Announces Closing of Delaware Basin Bronco Acquisition
May 15, 2017 20:08 pm UTC| Business
DENVER, May 15, 2017 -- Resolute Energy Corporation (“Resolute” or the “Company”) (NYSE:REN) today announced the closing of its previously announced Bronco acquisition of certain oil and gas properties located in Reeves...
Resolute Energy Corporation Announces Closing of Delaware Basin Bronco Acquisition
May 15, 2017 20:08 pm UTC| Business
DENVER, May 15, 2017 -- Resolute Energy Corporation (“Resolute” or the “Company”) (NYSE:REN) today announced the closing of its previously announced Bronco acquisition of certain oil and gas properties located in Reeves...
Resolute Energy Corporation Announces Closing of Delaware Basin Bronco Acquisition
May 15, 2017 20:08 pm UTC| Business
DENVER, May 15, 2017 -- Resolute Energy Corporation (“Resolute” or the “Company”) (NYSE:REN) today announced the closing of its previously announced Bronco acquisition of certain oil and gas properties located in Reeves...
Evoke Pharma Reports First Quarter 2017 Results
May 15, 2017 20:08 pm UTC| Business
Confirmed FDA acceptability of comparative exposure pharmacokinetic (PK) study design and agreement on related CMC data package elements for Gimoti™ new drug application (NDA)Partnered with Spaulding Clinical Research to...
Evoke Pharma Reports First Quarter 2017 Results
May 15, 2017 20:08 pm UTC| Business
Confirmed FDA acceptability of comparative exposure pharmacokinetic (PK) study design and agreement on related CMC data package elements for Gimoti™ new drug application (NDA)Partnered with Spaulding Clinical Research to...
Evoke Pharma Reports First Quarter 2017 Results
May 15, 2017 20:08 pm UTC| Business
Confirmed FDA acceptability of comparative exposure pharmacokinetic (PK) study design and agreement on related CMC data package elements for Gimoti™ new drug application (NDA)Partnered with Spaulding Clinical Research to...
Mother of All Deals: India & EU Seal Historic FTA After 20 Years